PublisherDOIYearVolumeIssuePageTitleAuthor(s)Link
Cancer Research and Treatment10.4143/crt.2020.741202153187-92Phase II Study of Pemetrexed as a Salvage Chemotherapy for Thymidylate Synthase–Low Squamous Cell Lung CancerMihong Choi, Heung Tae Kim, Ji-Youn Han, Geon Kook Lee, Soo-Hyun Lee, Kun Young Lim, Jungnam Joo, Hye Jin Won, Jin Soo Lee, Youngjoo Leehttp://e-crt.org/upload/pdf/crt-2020-741.pdf, http://e-crt.org/journal/view.php?doi=10.4143/crt.2020.741, http://e-crt.org/upload/pdf/crt-2020-741.pdf
BMC Cancer10.1186/1471-2407-14-2052014141The pemetrexed-containing treatments in the non-small cell lung cancer, is -/low thymidylate synthase expression better than +/high thymidylate synthase expression: a meta-analysisLei Wang, Rui Wang, Yunjian Pan, Yihua Sun, Jie Zhang, Haiquan Chenhttp://link.springer.com/content/pdf/10.1186/1471-2407-14-205.pdf, http://link.springer.com/article/10.1186/1471-2407-14-205/fulltext.html, http://link.springer.com/content/pdf/10.1186/1471-2407-14-205
Chest10.1378/chest.183240120141453349AThe Pemetrexed-Containing Treatments in the Non-small Cell Lung Cancer, Is -/Low Thymidylate Synthase Expression Better than +/High Thymidylate Synthase Expression? A Meta-analysisLei Wang, Rui Wang, Yunjian Pan, Yihua Sun, Jie Zhang, Haiquan Chenhttps://api.elsevier.com/content/article/PII:S0012369216460137?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0012369216460137?httpAccept=text/plain
Lung Cancer10.1016/s0169-5002(85)80114-8198513-482Unresectable non metastatic squamous cell carcinoma of the lung: Phase II study of radical radiotherapy and combined chemotherapyhttps://api.elsevier.com/content/article/PII:S0169500285801148?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500285801148?httpAccept=text/plain
Cancer Chemotherapy and Pharmacology10.1007/s00280-013-2218-62013722445-452Maintenance therapy with pemetrexed versus docetaxel after induction therapy with carboplatin and pemetrexed in chemotherapy-naïve patients with advanced non-squamous non-small-cell lung cancer: a randomized, phase II studyMasato Karayama, Naoki Inui, Shigeki Kuroishi, Koshi Yokomura, Mikio Toyoshima, Toshihiro Shirai, Masafumi Masuda, Takashi Yamada, Kazumasa Yasuda, Takafumi Suda, Kingo Chidahttp://link.springer.com/content/pdf/10.1007/s00280-013-2218-6.pdf, http://link.springer.com/article/10.1007/s00280-013-2218-6/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00280-013-2218-6
Clinical Lung Cancer10.3816/clc.2009.n.0272009103193-198PROCLAIM: A Phase III Study of Pemetrexed, Cisplatin, and Radiation Therapy Followed by Consolidation Pemetrexed Versus Etoposide, Cisplatin, and Radiation Therapy Followed by Consolidation Cytotoxic Chemotherapy of Choice in Locally Advanced Stage III Non–Small-Cell Lung Cancer of Other than Predominantly Squamous Cell HistologyEverett E. Vokes, Suresh Senan, Joseph A. Treat, Neill A. Iscoehttps://api.elsevier.com/content/article/PII:S1525730411704843?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S1525730411704843?httpAccept=text/plain
Cancer Chemotherapy and Pharmacology10.1007/s00280-013-2299-220137251125-1132Expression of thymidylate synthase predicts clinical outcomes of pemetrexed-containing chemotherapy for non-small-cell lung cancer: a systemic review and meta-analysisYu Liu, Tie-Jun Yin, Rong Zhou, Si Zhou, Liang Fan, Rong-Ge Zhanghttp://link.springer.com/content/pdf/10.1007/s00280-013-2299-2.pdf, http://link.springer.com/article/10.1007/s00280-013-2299-2/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00280-013-2299-2
Lung Cancer10.1016/s0169-5002(13)70044-8201379S1544 Review of the pemetrexed–cisplatin chemotherapy in non-squamous non-small cell lung cancer in Royal Shrewsbury HospitalC. Boon, A. Chatterjeehttps://api.elsevier.com/content/article/PII:S0169500213700448?httpAccept=text/xml, https://api.elsevier.com/content/article/PII:S0169500213700448?httpAccept=text/plain
Chemotherapy10.1159/0003430482012584313-320Pemetrexed for Previously Treated Patients with Non-Small Cell Lung Cancer and Differences in Efficacy according to Thymidylate Synthase ExpressionSatoshi Igawa, Shinichiro Ryuge, Mayuko Wada, Sakiko Otani, Sachiyo Maki, Akira Takakura, Ken Katono, Jiichiro Sasaki, Yuichi Sato, Noriyuki Masudahttps://www.karger.com/Article/Pdf/343048, http://www.karger.com/Article/Pdf/343048
Cancer Chemotherapy and Pharmacology10.1007/s00280-018-3573-020188161043-1050Phase II study of cisplatin/pemetrexed combined with bevacizumab followed by pemetrexed/bevacizumab maintenance therapy in patients with EGFR-wild advanced non-squamous non-small cell lung cancerToshirou Fukushima, Yuuki Wakatsuki, Takashi Kobayashi, Kei Sonehara, Kazunari Tateishi, Manabu Yamamoto, Takeshi Masubuchi, Fumiaki Yoshiike, Kazuya Hirai, Tsutomu Hachiya, Tomonobu Koizumihttp://link.springer.com/article/10.1007/s00280-018-3573-0/fulltext.html, http://link.springer.com/content/pdf/10.1007/s00280-018-3573-0.pdf, http://link.springer.com/content/pdf/10.1007/s00280-018-3573-0.pdf